To include your compound in the COVID-19 Resource Center, submit it here.

JNJ reports negative Topamax data

The R.W. Johnson Pharmaceutical Research Institute, a JNJ subsidiary, said its Topamax topiramate

Read the full 136 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE